AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 34445995 — intervention group
Group type: COMPARATOR
Intervention: Usual care clinic group (n=360)
Number of subjects: 840
Study 34445995 — intervention group
Group type: COMPARATOR
Intervention: Anticoagulation clinic group (n=120)
Number of subjects: 840
Study 36078768 — intervention group
Group type: EXPERIMENTAL
Intervention: Home-based pulmonary rehabilitation programme (HPRP) for 8 weeks with two hospital sessions
Number of subjects: 0
Study 36078768 — intervention group
Group type: EXPERIMENTAL
Intervention: Home-based pulmonary rehabilitation programme (HPRP)
Number of subjects: 0
Study 33068293 — intervention group
Group type: EXPERIMENTAL
Intervention: High-flow nasal cannula (HFNC) oxygen therapy
Number of subjects: 22
Study 33068293 — intervention group
Group type: COMPARATOR
Intervention: Conventional oxygen therapy (COT)
Number of subjects: 22
Study 32395842 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrophobic dressing (Cutimed Sorbact®)
Number of subjects: 204
Study 32395842 — intervention group
Group type: COMPARATOR
Intervention: Silver dressing (Aquacel® Ag Extra)
Number of subjects: 204
Study 36394933 — intervention group
Group type: EXPERIMENTAL
Intervention: Kombucha drink (KG), 220 ml, enriched with inulin (1.15 g/100 ml) for 10 days
Number of subjects: 40
Study 36394933 — intervention group
Group type: EXPERIMENTAL
Intervention: Kombucha drink (KG)
Number of subjects: 40
Study 36394933 — intervention group
Group type: COMPARATOR
Intervention: Water (Control Group, CG), 220 ml for 10 days
Number of subjects: 40
Study 34587911 — intervention group
Group type: EXPERIMENTAL
Intervention: Beta-lactam antibiotics plus fluoroquinolones
Number of subjects: 139
Study 34587911 — intervention group
Group type: COMPARATOR
Intervention: Beta-lactam antibiotics alone
Number of subjects: 139
Study 34571050 — intervention group
Group type: EXPERIMENTAL
Intervention: Rifaximin‐α (550 mg BID)
Number of subjects: 38
Study 32387064 — intervention group
Group type: EXPERIMENTAL
Intervention: Machine learning models (specifically the nonlinear XGBoost model)
Number of subjects: 26971
Study 32387064 — intervention group
Group type: EXPERIMENTAL
Intervention: Machine learning models (linear logistic regression)
Number of subjects: 26971
Study 32387064 — intervention group
Group type: EXPERIMENTAL
Intervention: Predicted intervention based on closing care gaps
Number of subjects: 26971
Study 32387064 — intervention group
Group type: EXPERIMENTAL
Intervention: Prioritizing patients for intervention using predicted reduction in 1-year mortality risk
Number of subjects: 26971
Study 32669450 — intervention group
Group type: EXPERIMENTAL
Intervention: Ixekizumab (80 mg every 2 weeks or every 4 weeks)
Number of subjects: 2
Study 32669450 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2
Study 32669450 — intervention group
Group type: COMPARATOR
Intervention: Adalimumab (bDMARD-naïve only)
Number of subjects: 2
Study 32669450 — intervention group
Group type: EXPERIMENTAL
Intervention: Ixekizumab (after rerandomization from placebo or adalimumab)
Number of subjects: 2
Study 32703583 — intervention group
Group type: EXPERIMENTAL
Intervention: Initial intravenous bolus of low-dose heparin (40 IU/kg)
Number of subjects: 904
Study 35337843 — intervention group
Group type: EXPERIMENTAL
Intervention: Hybrid Training System (HTS)
Number of subjects: 28
Study 35337843 — intervention group
Group type: COMPARATOR
Intervention: Sensory Transcutaneous Electrical Nerve Stimulation (TENS)
Number of subjects: 28
Study 33740589 — intervention group
Group type: EXPERIMENTAL
Intervention: Caffeine 200 mg administered in a double-blind fashion during PAS or tACS
Number of subjects: 60
Study 33740589 — intervention group
Group type: EXPERIMENTAL
Intervention: tACS (true) with caffeine
Number of subjects: 60
Study 33740589 — intervention group
Group type: COMPARATOR
Intervention: tACS (sham) with caffeine
Number of subjects: 60
Study 33740589 — intervention group
Group type: EXPERIMENTAL
Intervention: PAS and tACS
Number of subjects: 60
Study 33740589 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate caffeine consumption
Number of subjects: 60
Study 32203971 — intervention group
Group type: EXPERIMENTAL
Intervention: 3MDR
Number of subjects: 43
Study 32203971 — intervention group
Group type: COMPARATOR
Intervention: Control group (non-specific treatment component)
Number of subjects: 43
Study 35715198 — intervention group
Group type: EXPERIMENTAL
Intervention: NBO+EVT (100% oxygen via face mask, 10L/min for 4h)
Number of subjects: 86
Study 35715198 — intervention group
Group type: EXPERIMENTAL
Intervention: NBO+EVT
Number of subjects: 86
Study 33262033 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol
Number of subjects: 75
Study 33262033 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine
Number of subjects: 75
Study 33262033 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketofol
Number of subjects: 75
Study 34215667 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional genicular nerve radiofrequency ablation (GN‐RFA)
Number of subjects: 60
Study 34215667 — intervention group
Group type: COMPARATOR
Intervention: Sham control
Number of subjects: 60
Study 33289476 — intervention group
Group type: EXPERIMENTAL
Intervention: Biofeedback pelvic floor muscle training
Number of subjects: 300
Study 33289476 — intervention group
Group type: COMPARATOR
Intervention: Basic pelvic floor muscle training
Number of subjects: 300
Study 35902195 — intervention group
Group type: EXPERIMENTAL
Intervention: TEAS group (transcutaneous electrical acupoint stimulation)
Number of subjects: 1600
Study 33463568 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcaftadine 0.25%
Number of subjects: 180
Study 33463568 — intervention group
Group type: EXPERIMENTAL
Intervention: Olopatadine hydrochloride 0.2%
Number of subjects: 180
Study 33463568 — intervention group
Group type: EXPERIMENTAL
Intervention: Bepotastine besilate 1.5%
Number of subjects: 180
Study 33463568 — intervention group
Group type: COMPARATOR
Intervention: Bepotastine and Alcaftadine
Number of subjects: 180
Study 35301206 — intervention group
Group type: EXPERIMENTAL
Intervention: Endoscopic laser resection
Number of subjects: 100
Study 35301206 — intervention group
Group type: COMPARATOR
Intervention: Endoscopic dilation
Number of subjects: 100
Study 33129442 — intervention group
Group type: EXPERIMENTAL
Intervention: Ocrelizumab
Number of subjects: 732
Study 34498782 — intervention group
Group type: EXPERIMENTAL
Intervention: Targeted bronchiolitis interventions
Number of subjects: 1958
Study 34753900 — intervention group
Group type: EXPERIMENTAL
Intervention: Egg Breakfast (EB)
Number of subjects: 48
Study 34753900 — intervention group
Group type: EXPERIMENTAL
Intervention: Saturated Fat Breakfast (SB)
Number of subjects: 48
Study 34753900 — intervention group
Group type: EXPERIMENTAL
Intervention: Eggs and Saturated Fat Breakfast (ES)
Number of subjects: 48
Study 34753900 — intervention group
Group type: COMPARATOR
Intervention: Control Breakfast (CB)
Number of subjects: 48
Study 36039846 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive intervention group (nutritional education at every outpatient visit)
Number of subjects: 96
Study 36039846 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive intervention group
Number of subjects: 96
Study 36039846 — intervention group
Group type: COMPARATOR
Intervention: Control group (nutritional education once a year)
Number of subjects: 96
Study 33320777 — intervention group
Group type: EXPERIMENTAL
Intervention: High-fructose corn syrup
Number of subjects: 1000
Study 33320777 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspartame
Number of subjects: 1000
Study 33320777 — intervention group
Group type: EXPERIMENTAL
Intervention: Raw sugar
Number of subjects: 1000
Study 33320777 — intervention group
Group type: EXPERIMENTAL
Intervention: Attempted to consume less sugar
Number of subjects: 1000
Study 33320777 — intervention group
Group type: EXPERIMENTAL
Intervention: Attempted to consume less 'artificial' low-calorie sweeteners
Number of subjects: 1000
Study 33320777 — intervention group
Group type: EXPERIMENTAL
Intervention: Attempted to consume less 'natural' low-calorie sweeteners
Number of subjects: 1000
Study 33913260 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous anifrolumab (150/300 mg once every 4 weeks)
Number of subjects: 819
Study 35761841 — intervention group
Group type: EXPERIMENTAL
Intervention: PDL1/PD-1 inhibitors
Number of subjects: 116
Study 35761841 — intervention group
Group type: COMPARATOR
Intervention: FOLFIRINOX regimen
Number of subjects: 116
Study 33478890 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient functional status (measured by Eastern Cooperative Oncology Group)
Number of subjects: 441
Study 33478890 — intervention group
Group type: EXPERIMENTAL
Intervention: Quality of life (measured by Functional Assessment of Chronic Illness Therapy – Palliative Care)
Number of subjects: 441
Study 33478890 — intervention group
Group type: EXPERIMENTAL
Intervention: Anxiety (measured by Hospital Anxiety and Depression Scale)
Number of subjects: 441
Study 33478890 — intervention group
Group type: EXPERIMENTAL
Intervention: Depression (measured by Hospital Anxiety and Depression Scale)
Number of subjects: 441
Study 34016828 — intervention group
Group type: EXPERIMENTAL
Intervention: Excessive screen time (more than 1 hour per day)
Number of subjects: 400
Study 34016828 — intervention group
Group type: EXPERIMENTAL
Intervention: Screen time on weekdays
Number of subjects: 400
Study 34016828 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher screen time correlation with mother's education
Number of subjects: 400
Study 34016828 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher screen time correlation with family income
Number of subjects: 400
Study 34016828 — intervention group
Group type: EXPERIMENTAL
Intervention: Daycare attendance
Number of subjects: 400
Study 34016828 — intervention group
Group type: EXPERIMENTAL
Intervention: Caregivers' screen time
Number of subjects: 400
Study 34016828 — intervention group
Group type: EXPERIMENTAL
Intervention: Absence of digital-media rules
Number of subjects: 400
Study 34016828 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower mother's education
Number of subjects: 400
Study 34016828 — intervention group
Group type: EXPERIMENTAL
Intervention: Watching educational digital content
Number of subjects: 400
Study 35439521 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyaluronic acid and hypertonic dextrose
Number of subjects: 104
Study 35439521 — intervention group
Group type: COMPARATOR
Intervention: Hyaluronic acid and normal saline
Number of subjects: 104
Study 33857680 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness-Based Relapse Prevention (MBRP)
Number of subjects: 0
Study 33857680 — intervention group
Group type: COMPARATOR
Intervention: 12-Step Facilitation (TSF)
Number of subjects: 0
Study 32327669 — intervention group
Group type: COMPARATOR
Intervention: Micro-dosing application of 30.75 kg N ha-1 and 34.5 kg P2O5 ha-1 (N applied in three splits: 1/3 at sowing, 1/3 at emergence, and 1/3 at 45 days after emergence) at Aybra.
Number of subjects: 0
Study 32327669 — intervention group
Group type: COMPARATOR
Intervention: Micro-dosing application of 20.5 kg N ha-1 and 23 kg P2O5 ha-1 (N applied in three splits: 1/3 at sowing, 1/3 at emergence, and 1/3 at 45 days after emergence) at Shumshiha-Lasta Lalibela.
Number of subjects: 0
Study 32327669 — intervention group
Group type: COMPARATOR
Intervention: Recommended NP application of 41 kg N ha-1 and 46 kg P2O5 ha-1.
Number of subjects: 0
Study 32327669 — intervention group
Group type: COMPARATOR
Intervention: Control (without fertilizer).
Number of subjects: 0
Study 36078324 — intervention group
Group type: EXPERIMENTAL
Intervention: High-Intensity Functional Training (HIFT)
Number of subjects: 69
Study 36078324 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate-Intensity Continuous Training (MICT)
Number of subjects: 69
Study 36078324 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 69
Study 33736592 — intervention group
Group type: EXPERIMENTAL
Intervention: Home-based exercises (resistance exercise, stretching, and aerobic exercise such as walking) for 6 months
Number of subjects: 53
Study 33736592 — intervention group
Group type: COMPARATOR
Intervention: Usual-care group (stretching and usual physical activity)
Number of subjects: 53
Study 34417673 — intervention group
Group type: EXPERIMENTAL
Intervention: Anti-beta-1-adrenergic receptor antibodies (anti-β1-AR) in patients with CCM
Number of subjects: 3
Study 33047657 — intervention group
Group type: EXPERIMENTAL
Intervention: Professional Values Development Programme (12-week duration)
Number of subjects: 80
Study 33047657 — intervention group
Group type: COMPARATOR
Intervention: Control group (received the programme after data collection)
Number of subjects: 80
Study 32739716 — intervention group
Group type: EXPERIMENTAL
Intervention: Study Condition #1 (SC1) - accessed an online eHealth resource and generally available resources
Number of subjects: 217
Study 32739716 — intervention group
Group type: COMPARATOR
Intervention: Study Condition #2 (SC2) - accessed only generally available resources
Number of subjects: 217
Study 35788824 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive blood pressure lowering
Number of subjects: 300
Study 35788824 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 300
Study 35451351 — intervention group
Group type: EXPERIMENTAL
Intervention: VasQTM device
Number of subjects: 6
Study 35451351 — intervention group
Group type: COMPARATOR
Intervention: Control group (conventional surgery)
Number of subjects: 6
Study 33218873 — intervention group
Group type: EXPERIMENTAL
Intervention: Brain Endurance Training (BET) group completed concurrent cognitive tasks (2-back, Stroop) during 24 submaximal hand contractions sessions over 6 weeks.
Number of subjects: 36
Study 33218873 — intervention group
Group type: COMPARATOR
Intervention: Control group completed 24 submaximal hand contractions sessions over 6 weeks without concurrent cognitive tasks.
Number of subjects: 36
Study 33218873 — intervention group
Group type: EXPERIMENTAL
Intervention: BET group compared to Control group regarding pre-frontal oxygenation during post-training physical tasks.
Number of subjects: 36
Study 32878524 — intervention group
Group type: EXPERIMENTAL
Intervention: Timetabled primary care sessions in all three clinical years
Number of subjects: 390
Study 32878524 — intervention group
Group type: EXPERIMENTAL
Intervention: Enrolling in rural medical student recruitment schemes
Number of subjects: 390
Study 32878524 — intervention group
Group type: EXPERIMENTAL
Intervention: Valuing core values of GP
Number of subjects: 390
Study 33310604 — intervention group
Group type: EXPERIMENTAL
Intervention: Meditation program involving daily use of the 'Muse' device for eight weeks
Number of subjects: 71
Study 33310604 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control
Number of subjects: 71
Study 33247008 — intervention group
Group type: EXPERIMENTAL
Intervention: 3D-printed brace
Number of subjects: 88
Study 33247008 — intervention group
Group type: COMPARATOR
Intervention: TLSO (thoracolumbosacral orthoses)
Number of subjects: 88
Study 35183257 — intervention group
Group type: EXPERIMENTAL
Intervention: Early-support intervention (eight-component support including training, sharing of experience, audit-and-feedback, and resource support)
Number of subjects: 43054
Study 32889444 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness‐Based Relapse Prevention (MBRP)
Number of subjects: 221
Study 32889444 — intervention group
Group type: COMPARATOR
Intervention: Treatment as Usual (TAU)
Number of subjects: 221
Study 32889444 — intervention group
Group type: COMPARATOR
Intervention: Relapse Prevention (RP)
Number of subjects: 221
Study 33072380 — intervention group
Group type: EXPERIMENTAL
Intervention: Intradialytic progressive resistance exercise (IPRE)
Number of subjects: 87
Study 33072380 — intervention group
Group type: COMPARATOR
Intervention: Control group (haemodialysis session alone)
Number of subjects: 87
Study 35260292 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-Behavioral Therapy (CBT) by telephone
Number of subjects: 500
Study 35260292 — intervention group
Group type: EXPERIMENTAL
Intervention: Yoga (in-person group classes)
Number of subjects: 500
Study 35260292 — intervention group
Group type: COMPARATOR
Intervention: Randomized controlled trial (RCT) of CBT or yoga
Number of subjects: 500
Study 35260292 — intervention group
Group type: COMPARATOR
Intervention: Preference trial (selected CBT or yoga)
Number of subjects: 500
Study 33720893 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic training (n=13)
Number of subjects: 27
Study 33720893 — intervention group
Group type: COMPARATOR
Intervention: Balance and toning (BAT) control group (n=14)
Number of subjects: 27
Study 32789664 — intervention group
Group type: EXPERIMENTAL
Intervention: Response-oriented feedback
Number of subjects: 64
Study 32789664 — intervention group
Group type: EXPERIMENTAL
Intervention: Conceptually focused feedback
Number of subjects: 64
Study 32789664 — intervention group
Group type: COMPARATOR
Intervention: Right/wrong feedback
Number of subjects: 64
Study 32789664 — intervention group
Group type: EXPERIMENTAL
Intervention: Initial test occasion
Number of subjects: 64
Study 32789664 — intervention group
Group type: EXPERIMENTAL
Intervention: Far transfer tasks
Number of subjects: 64
Study 32789664 — intervention group
Group type: EXPERIMENTAL
Intervention: Near transfer tasks
Number of subjects: 64
Study 35029231 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent theta burst stimulation (iTBS)
Number of subjects: 47
Study 35029231 — intervention group
Group type: EXPERIMENTAL
Intervention: High-frequency repetitive transcranial magnetic stimulation (rTMS)
Number of subjects: 47
Study 33556861 — intervention group
Group type: EXPERIMENTAL
Intervention: Modular cognitive behavioral intervention delivered by trained healthcare professionals (HCPs) over 6 months
Number of subjects: 34
Study 32103319 — intervention group
Group type: EXPERIMENTAL
Intervention: Two whole apples daily for 8 weeks
Number of subjects: 40
Study 32103319 — intervention group
Group type: COMPARATOR
Intervention: Sugar and energy-matched control beverage
Number of subjects: 40
Study 34558768 — intervention group
Group type: EXPERIMENTAL
Intervention: Empagliflozin (10 or 25 mg)
Number of subjects: 7020
Study 34240673 — intervention group
Group type: EXPERIMENTAL
Intervention: Risedronate (35 mg/week)
Number of subjects: 281
Study 34240673 — intervention group
Group type: COMPARATOR
Intervention: Menopausal hormone therapy (MHT) - estradiol gel (1.5 mg/day) + oral micronized progesterone (100 mg/day)
Number of subjects: 281
Study 32434932 — intervention group
Group type: EXPERIMENTAL
Intervention: Ecologic Femi+ (EF+) vaginal capsule
Number of subjects: 68
Study 32434932 — intervention group
Group type: EXPERIMENTAL
Intervention: Gynophilus LP (GynLP) vaginal tablet
Number of subjects: 68
Study 32434932 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral metronidazole
Number of subjects: 68
Study 32434932 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioural counselling only
Number of subjects: 68
Study 32434932 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall adherence and acceptability of probiotics
Number of subjects: 68
Study 32434932 — intervention group
Group type: EXPERIMENTAL
Intervention: Vaginal washing practices
Number of subjects: 68
Study 32434932 — intervention group
Group type: EXPERIMENTAL
Intervention: Sexual risk behaviours
Number of subjects: 68
Study 32434932 — intervention group
Group type: EXPERIMENTAL
Intervention: Knowledge about vaginal infections
Number of subjects: 68
Study 35455518 — intervention group
Group type: EXPERIMENTAL
Intervention: Mother‐Infant Transaction Program‐Modified (MITP‐M, n = 72)
Number of subjects: 146
Study 35455518 — intervention group
Group type: COMPARATOR
Intervention: Preterm control group (n = 74)
Number of subjects: 146
Study 32347764 — intervention group
Group type: EXPERIMENTAL
Intervention: Liquefied petroleum gas stoves and fuel
Number of subjects: 3200
Study 32347764 — intervention group
Group type: EXPERIMENTAL
Intervention: Stove use monitors (Geocene)
Number of subjects: 3200
Study 32347764 — intervention group
Group type: EXPERIMENTAL
Intervention: Ambient air monitoring
Number of subjects: 3200
Study 35105307 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical local anesthesia with EMLA®
Number of subjects: 120
Study 35105307 — intervention group
Group type: COMPARATOR
Intervention: Sterile water injections without topical local anesthesia (Control group 1)
Number of subjects: 120
Study 35105307 — intervention group
Group type: COMPARATOR
Intervention: Isotonic saline 0.9% with topical local anesthesia (Control group 2)
Number of subjects: 120
Study 35105307 — intervention group
Group type: COMPARATOR
Intervention: Isotonic saline 0.9% without topical local anesthesia (Control group 3)
Number of subjects: 120
Study 33121861 — intervention group
Group type: EXPERIMENTAL
Intervention: Music therapy (preferred genre played during treatment)
Number of subjects: 102
Study 33121861 — intervention group
Group type: COMPARATOR
Intervention: No music (control group)
Number of subjects: 102
Study 35125224 — intervention group
Group type: EXPERIMENTAL
Intervention: MAS-1 adjuvanted IIV (0.3 mL, 9 µg per HA)
Number of subjects: 45
Study 35125224 — intervention group
Group type: EXPERIMENTAL
Intervention: MAS-1 adjuvanted IIV (0.5 mL, 9 µg per HA)
Number of subjects: 45
Study 35125224 — intervention group
Group type: COMPARATOR
Intervention: High dose IIV (Fluzone HD, 60 µg per HA)
Number of subjects: 45
Study 35125224 — intervention group
Group type: EXPERIMENTAL
Intervention: MAS-1 adjuvanted IIV
Number of subjects: 45
Study 33777428 — intervention group
Group type: EXPERIMENTAL
Intervention: Falls among elderly individuals
Number of subjects: 269
Study 33777428 — intervention group
Group type: EXPERIMENTAL
Intervention: Gender comparison of falls
Number of subjects: 269
Study 33777428 — intervention group
Group type: EXPERIMENTAL
Intervention: Location of falls
Number of subjects: 269
Study 33777428 — intervention group
Group type: EXPERIMENTAL
Intervention: Age risk factor
Number of subjects: 269
Study 33777428 — intervention group
Group type: EXPERIMENTAL
Intervention: Polypharmacy risk factor
Number of subjects: 269
Study 33777428 — intervention group
Group type: EXPERIMENTAL
Intervention: Environmental factors risk factor
Number of subjects: 269
Study 33777428 — intervention group
Group type: EXPERIMENTAL
Intervention: Education level risk factor
Number of subjects: 269
Study 33777428 — intervention group
Group type: EXPERIMENTAL
Intervention: MAHC‐10 fall risk score
Number of subjects: 269
Study 32267783 — intervention group
Group type: EXPERIMENTAL
Intervention: Apnea training
Number of subjects: 40
Study 32267783 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 40
Study 34713471 — intervention group
Group type: EXPERIMENTAL
Intervention: Systemic metronidazole
Number of subjects: 32
Study 34713471 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32
Study 34237655 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium oxybate (SMO) 0.75, 1.25, 1.75 or 2.25 g t.i.d. for 12 weeks
Number of subjects: 509